Prevalence of PICC-related thrombosis in patients with hematological malignancies: a systematic review
BN Dos Santos, BVG Beato, EB Ferreira… - Supportive Care in …, 2024 - Springer
Purpose To estimate the prevalence of peripherally inserted central catheter (PICC)-related
venous thrombosis in patients with hematological malignancies. Methods A systematic …
venous thrombosis in patients with hematological malignancies. Methods A systematic …
Central venous catheter–associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice
CH van den Bosch, J Spijkerman, MHWA Wijnen… - Supportive Care in …, 2022 - Springer
Purpose The purpose of this study was to determine the most optimal central venous
catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications …
catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications …
Patient preferences and willingness to pay for central venous access devices in breast cancer: A multicenter discrete choice experiment
S Liu, Y Xiang, Y Gu, N Chen, P Fu, Y Wei… - International Journal of …, 2024 - Elsevier
Background Despite being a significant management decision in clinical or nursing practice,
there is limited understanding of the preferences regarding risks, benefits, costs, and other …
there is limited understanding of the preferences regarding risks, benefits, costs, and other …
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
J Rincon-Torroella, MD Molin, B Mog, G Han, E Watson… - bioRxiv, 2023 - biorxiv.org
Nearly 30% of Pancreatic ductal adenocarcinoma (PDAC) s exhibit a marked
overexpression of Monocarboxylate Transporter 1 (MCT1) offering a unique opportunity for …
overexpression of Monocarboxylate Transporter 1 (MCT1) offering a unique opportunity for …
Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation
Objectives Patients undergoing long-term anticancer therapy typically require one of 3
venous access devices: Hickman-type device (HICK), peripherally inserted central catheter …
venous access devices: Hickman-type device (HICK), peripherally inserted central catheter …
[PDF][PDF] Incorporating implementation within the economic evaluation of health technologies
R Heggie - 2023 - theses.gla.ac.uk
Background Delayed or insufficient implementation of clinically effective and cost-effective
health technologies leads to poorer health outcomes for patients and the sub-optimal use of …
health technologies leads to poorer health outcomes for patients and the sub-optimal use of …
Prevalência de trombose relacionada ao cateter central de inserção periférica em pacientes onco-hematológicos: revisão sistemática de prevalência
BNS Martins - teses.usp.br
O Cateter Central de Inserção Periférica (PICC) tem sido amplamente utilizado no
tratamento de pacientes onco-hematológicos pela sua facilidade de inserção e menor risco …
tratamento de pacientes onco-hematológicos pela sua facilidade de inserção e menor risco …
[PDF][PDF] HOSPITAL GENERAL DE MÉXICO “DR. EDUARDO LICEAGA”
IT PALOMEQUE - 2022 - ru.dgb.unam.mx
1. ANTECEDENTES La reanimación cardiopulmonar es una intervención que salva vidas,
la supervivencia del paro cardiaco depende del reconocimiento temprano del paro y la …
la supervivencia del paro cardiaco depende del reconocimiento temprano del paro y la …
[引用][C] Ambulatory 5-Fluorouracil Infusors: Experiences of Patients Diagnosed with Gastrointestinal Cancer
T Huber - 2023